GlassScriptPhysician profile
Manpreet Kaur
NPI 1982023909
$2,187.92
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $376 · 2022: $859 · 2023: $952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $333.74 | 2020-2023 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $307.23 | 2022-2023 | Spiriva Respimat, Jardiance |
| Abbvie INC. | $292.49 | 2022-2023 | |
| Lilly USA, LLC | $240.25 | 2022-2023 | Mounjaro, Jardiance, Trulicity |
| Astellas Pharma US INC | $210.14 | 2020-2023 | Veozah, Myrbetriq |
| Abbott Laboratories | $180.64 | 2022-2023 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $128.80 | 2020-2023 | Trelegy Ellipta, Arexvy |
| Sanofi-Aventis U.S. LLC | $80.18 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $54.31 | 2022 | |
| Boston Scientific Corporation | $47.09 | 2022 | |
| Pfizer INC. | $39.45 | 2020-2023 | |
| Mannkind Corporation | $31.81 | 2020 | |
| Janssen Pharmaceuticals, INC | $31.51 | 2020-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $26.52 | 2020 | |
| Antares Pharma, INC. | $25.51 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $24.27 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $24.01 | 2020 | |
| Exact Sciences Corporation | $19.83 | 2023 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $18.90 | 2020 | |
| Sumitomo Pharma America, INC. | $16.52 | 2023 | Gemtesa |
| Amgen INC. | $15.14 | 2020 | |
| Medtronic Minimed, INC. | $13.81 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.00 | 2020 | |
| Dexcom, INC. | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manpreet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.